NUCLEUS RADIOPHARMA Trademark

Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Consulting services in the field of pharmaceutical research; Laboratory services for the production of pharmaceutical products; Medical and scientific research, namely, conducting clinical trials for others; Medical research in the field of immunotherapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Custom manufacturing of pharmaceuticals

Isotopes for industrial purposes; Chemical additives for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemical agents for chelating and sequestering

Medical apparatus and instruments for diagnostic radiopharmaceutical use; Containers and trays specially designed for transporting and holding radiopharmaceuticals; Injection device for pharmaceuticals; Radiological apparatus for medical purposes; Radioisotope therapy apparatus and instruments; Medical diagnostic apparatus for detecting cancer; Medical apparatus and instruments for use in positron emission tomography (PET) imaging; Medical apparatus for introducing pharmaceutical preparations into the human body

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Providing medical information via a website; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Pharmaceutical compounding services

Pharmaceutical preparations for the treatment of cancer; Radiopharmaceutical preparations for the treatment of cancers, orphan diseases, and tumors; Diagnostic radiopharmaceutical preparations; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Diagnostic reagents for medical use in in vitro diagnosis; Radio-isotope markers for therapeutic or diagnostic use; Diagnostic radiopharmaceutical agent for use in PET imaging; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Radiological contrast substances for medical purposes